 REHOVOT, Israel and WILMINGTON, Del., Jan. 13, 2021 GLOBE NEWSWIRE -- Ayala Pharmaceuticals, Inc. NASDAQ: AYLA, a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that Roni Mamluk, Ph.D., Chief Executive Officer of Ayala, will present at the Noble Capital Markets 17th Annual Small Microcap Investor Conference on Wednesday, January 20, 2021 at 1:30 pm ET. 